Internal Medicine, Rheumatology · Palm Springs, CA
NPI
1518026483
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
275 N. El Cielo
Palm Springs, CA, 92262
Phone (760) 323-8657
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$932K
1,070 prescriptions
Company payments, 2024
$148
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug Michael R Lovy prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 179 prescriptions and refills. In total Michael R Lovy wrote 1,070 Medicare prescriptions that cost $932K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-28.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Hydroxychloroquine Sulfate Generic | 179 | 452 | 67 | $9,644 |
| Prednisone Generic | 96 | 228 | 33 | $965 |
| Teriparatide Generic | 51 | 51 | Under 11 | $162K |
| Omeprazole Generic | 50 | 137 | 20 | $1,050 |
| Methotrexate Methotrexate Sodium | 47 | 104 | 19 | $1,008 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 44 | 112 | 19 | $1,953 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 40 | 42 | Under 11 | $844 |
| Gabapentin Generic | 39 | 89 | 19 | $985 |
| Tramadol Hcl Generic | 37 | 40 | 17 | $214 |
| Enbrel Sureclick Etanercept | 27 | 27 | Under 11 | $210K |
| Evenity Romosozumab-Aqqg | 26 | 26 | Under 11 | $65K |
| Prolia Denosumab | 24 | 144 | 17 | $42K |
| Duloxetine Hcl Generic | 23 | 42 | Under 11 | $390 |
| Celecoxib Generic | 20 | 45 | Under 11 | $475 |
| Leflunomide Generic | 19 | 50 | 12 | $1,373 |
Brand drugs: 234 claims; generic drugs: 734 claims; opioid claims: 38.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Michael R Lovy $148 ($148 in general payments such as food, travel and fees) from 3 companies. The largest payer was Genzyme Corporation with $62.08.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.